Is a complete BCTX research report available?

No complete published report is available for BriaCell Therapeutics Corp. (BCTX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

BriaCell Therapeutics Corp. (BCTX)

NASDAQ: BCTX · USD

$3.63

+0.23 (+6.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BCTX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	29.8M
Net income (ttm)	-30.7M
EPS (ttm)	-$9.66
Shares out	8.7M
Volume	72,191
Beta	1.54

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -30.7M
EPS (ttm): -$9.66
Market cap: 29.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BCTX indicators

Market & fundamental data

Available fields

171

Groups with data

Currency

USD

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001610820
Company name	BriaCell Therapeutics Corp.
Country	Canada
Country code	US
Cusip	107930307
Employees	16
Employees Change	10%
Employees Change Percent	166.7
Enterprise value	$7.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	CA1079303071
Last refreshed	2026-07-31
Market cap	$29.8M
Market cap category	Nano-Cap
Price	$3.63
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	BCTX
Website	https://briacell.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-102.86%
FCF yield	-103.79%
P/B ratio	1.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-30.7M
Net Income Growth Years	0%
Profit Per Employee	$-1.9M
ROA	-90.84
Roa5y	-65.05
ROCE	-126.2
ROE	-175.3
ROIC	-113.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-53.49%
Cagr1y	-54.94%
Cagr3y	-84.31%
Cagr5y	-66.21%
EPS Growth Quarters	4
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$27.1M
Cash	$22.8M
Current Assets	$25.4M
Current Liabilities	$3.6M
Debt	$0
Equity	$23.4M
Interest Coverage	-999.9
Liabilities	$3.7M
Long Term Assets	$1.7M
Long Term Liabilities	$71,854
Net Cash	$22.8M
Net Cash By Market Cap	$76.47
Net Cash Growth	83.02%
Net Debt Equity	$-0.97
Tangible Book Value	$23.9M
Tangible Book Value Per Share	$3.29
WACC	12.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.07
Net Working Capital	$-1M
Quick ratio	6.35
Working Capital	$21.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1,260.31%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.95%
1Y total return	-54.92%
200-day SMA	5.81
3Y total return	-99.61%
50-day SMA	3.37
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.56%
All Time High	14,400.1
All Time High Change	-99.97%
All Time High Date	2015-04-22
All Time Low	2.6
All Time Low Change	39.62%
All Time Low Date	2026-06-11
ATR	0.26
Beta	1.54
Ch YTD	-48.95
High	3.79
High52	14.68
High52 Date	2025-10-21
High52ch	-75.27%
Low	3.44
Low52	2.6
Low52 Date	2026-06-11
Low52ch	39.62%
Ma50ch	7.62%
Price vs 200-day SMA	-37.52%
RSI	52.99
RSI Monthly	32.42
RSI Weekly	38.49
Sharpe ratio	-0.08x
Sortino ratio	-0.06
Total Return	-1,260.31%
Tr YTD	-48.95
Tr1m	17.1%
Tr1w	-2.42%
Tr3m	-9.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-32M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,859,584%
Float Percent	90.34%
Shares Insiders	2.1%
Shares Institutions	6.37%
Shares Out	8,699,787
Shares Qo Q	158.73%
Shares Yo Y	1,260.31%
Short Float	5.7%
Short Ratio	2.64
Short Shares	5.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-32M
Adjusted OCF	-31,837,646
Average Volume	150,180.3x
Bv Per Share	3.32
CAPEX	$-127,049
Ch10y	-99.95
Ch1m	17.1
Ch1w	-2.42
Ch1y	-54.92
Ch3m	-9.7
Ch3y	-99.61
Ch5y	-99.56
Ch6m	-15.78
Change	6.76%
Change From Open	4.01
Close	3.4
Days Gap	2.65
Depreciation Amortization	112,981
Dollar Volume	262,053.3
Earnings Date	2026-06-09
Earnings Time	amc
EBIT	$-29.6M
EBITDA	$-29.5M
EPS	$-9.66
F Score	1
FCF	$-31M
FCF EV Yield	-432.05x
FCF Per Share	$-3.56
Financing CF	41,431,441
Fiscal Year End	July
Founded	2,014
Investing CF	-16,186,576
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-06-09
Last Report Date	2026-04-30
Last Split Date	2025-08-25
Last Split Type	Reverse
Last10k Filing Date	2025-10-16
Ma150	4.23
Ma150ch	-14.08%
Ma20	3.64
Ma20ch	-0.33%
Net CF	-5,580,032
Next Earnings Date	2026-10-15
Open	3.49
Optionable	Yes
Position In Range	54.29
Post Close	3.63
Postmarket Change Percent	-1.38
Postmarket Price	$3.58
Ppne	348,997
Price Date	2026-07-30
Ptbv Ratio	1.25
Relative Volume	0.48x
Share Based Comp	1,012,749
Tr6m	-15.78%
Volume	72,191

BriaCell Therapeutics Corp. (BCTX)

Coverage state: Market snapshot only — no published research

Generate the first BCTX analysis

Price

Financial snapshot

Fair-value bridge

Latest news · BCTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BCTX

Frequently asked questions